Skip to main navigation
CG Oncology logo
  • Home
  • About
    • Overview
    • Executive Leadership
    • Board of Directors
  • Science
    • Mechanism of Action
    • Unmet Need in Bladder Cancer
    • Abstracts & Presentations
    • Video Library
  • Clinical Studies
    • Pipeline
    • Ongoing Clinical Studies
    • PIVOT-006
    • Expanded Patient Access
  • Investor Relations
    • Overview
    • News & Events
      • Press Releases
      • Events & Conferences
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Annual Reports
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Media
    • CG in the News
    • Media Resources
  • Careers
  • Contact
/investor-relations

Quarterly Results

Show all

2024

Q1

  • CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
  • Form 10-Q
logo footer

CG ONCOLOGY, INC.
400 Spectrum Center Drive
Suite 2040
Irvine, CA 92618

  • Twitter opens in new window
  • LinkedIn opens in new window

GENERAL INQUIRIES

information@cgoncology.com


MEDICAL AFFAIRS

medicalaffairs@cgoncology.com

MEDIA

mediarelations@cgoncology.com


PARTNERS

bd@cgoncology.com


INVESTORS

ir@cgoncology.com

Privacy Policy
Terms of Service
Copyright All Rights Reserved CG Oncology | © 2024

US-UNBR-1007-v1 03/2024

Search Investors